Trial Profile
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2018
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary) ; Amoxicillin; Clarithromycin; Metronidazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 24 Oct 2018 Results presented at the 26th United European Gastroenterology Week
- 29 Dec 2016 Status changed from active, no longer recruiting to completed.
- 10 Apr 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Feb 2017, as reported by ClinicalTrials.gov.